reRe re re July 4

Kent WA

Description

Pfizer’s vaccine received full FDA approval, which means more data show how well that particular vaccine works. The FDA may fully approve the Moderna coronavirus vaccine and others in the future. https://www.hopkinsmedicine.org/health/conditions-and-diseases/coronavirus/full-fda-approval-of-a-covid-19-vaccine-what-you-should-know The two Pfizer and Moderna mRNA vaccines are very safe and very good at preventing serious or FATAL cases of COVID- The risk of serious side effects associated with these vaccines is very small (the bullet proof vest analogy). The FDA added a warning label on the mRNA vaccines regarding serious (but rare) cases of inflammation of the heart muscle (myocarditis) and of the outer lining of the heart (pericarditis) in adolescents and young adults, more often occurring after the second dose of an mRNA vaccine. The inflammation, in most cases, gets better on its own without treatment. One study determined that people were eight to ten times more likely to develop blood clots in the brain from having COVID itself rather than from receiving either of the Pfizer or Moderna vaccines. https://www.cidrap.umn.edu/news-perspective/2021/04/study-covid-much-more-likely-vaccines-cause-blood-clots The New England Journal of Medicine in September 2021 showed Pfizer-BioNTech to be 88.8% effective in preventing symptomatic illness in 5,000 health care workers, compared to 96.3% for Moderna. Then, as 2021 progressed—and the Omicron variant emerged--studies showed declines in vaccine effectiveness, and that contributed to the CDC’s decision to approve Food and Drug Administration (FDA) authorizations toward the end of last year for booster shots. https://www.hopkinsmedicine.org/health/conditions-and-diseases/coronavirus/full-fda-approval-of-a-covid-19-vaccine-what-you-should-know Clinical trials: The FDA requires rigorous testing of vaccines through a series of clinical trials to make sure they work and are safe before authorizing or approving them for the public. The laboratories that conduct the trials are independent from the vaccine companies and the government, so the information they convey to the FDA for its approval process is not biased. Risks and benefits: FDA approval of a vaccine involves careful assessment of risks and benefits. Before approval can happen, the clinical trials and other data used by the agency must demonstrate that the benefits of a vaccine are greater than its risks for those who will be vaccinated. Continual monitoring: After authorization or approval, monitoring continues: The FDA continues to examine data for adverse effects among the people receiving the vaccine. If any problems are linked to a vaccine, the FDA may pause the administration of that vaccine to do more studies and ensure that the problem does not outweigh the vaccine’s benefit. Manufacturing guidelines. The FDA also sets strict guidelines for vaccine manufacturers and requires that they test the vaccine doses in batches (lots) to ensure the quality and effectiveness of the vaccines remain consistent and reliable. The relatively quick development of these vaccines does not mean safety measures were skipped. There are several reasons why the COVID-19 vaccines were developed faster than other vaccines: The technologies used to develop the COVID-19 vaccines have been in development for years to prepare for outbreaks of infectious viruses. The manufacturing processes were ready very early in the COVID-19 pandemic. Countries shared genetic information when it was available about SARS-CoV-2, the coronavirus that causes COVID-19, which gave vaccine developers an early start at finding a vaccine. The testing processes for the vaccines didn’t skip any steps, but the vaccine developers conducted some stages of the process simultaneously to gather as much data as quickly as possible. Governments gave money to vaccine developers in advance, so the companies had resources they needed. Some types of COVID-19 vaccines were created using messenger RNA (mRNA), a new technology that allows a faster approach than the traditional way vaccines are made. Social media enabled companies to reach out to and enroll study volunteers, and plenty of people wanted to help, so there were enough research participants to test the COVID-19 vaccines. Because SARS-CoV-2 is so contagious and widespread, many volunteers who got the vaccines were exposed to the virus, and with so many exposures, it took a shorter time to see if the vaccines worked. Companies began manufacturing vaccines ahead of their authorization or approval so some supplies would be ready if authorization occurred. If you're not going to be vaccinated for Covid be sure to stay at home. If you can't stay at home wear a mask when you go out in public. The relatively quick development of these vaccines does not mean safety measures were skipped. There are several reasons why the COVID-19 vaccines were developed faster than other vaccines: The technologies used to develop the COVID-19 vaccines have been in development for years to prepare for outbreaks of infectious viruses. The manufacturing processes were ready very early in the COVID-19 pandemic. Countries shared genetic information when it was available about SARS-CoV-2, the coronavirus that causes COVID-19, which gave vaccine developers an early start at finding a vaccine. The testing processes for the vaccines didn’t skip any steps, but the vaccine developers conducted some stages of the process simultaneously to gather as much data as quickly as possible. Governments gave money to vaccine developers in advance, so the companies had resources they needed. Some types of COVID-19 vaccines were created using messenger RNA (mRNA), a new technology that allows a faster approach than the traditional way vaccines are made. It does NOT alter DNA. It only makes a spike protein copy for the immune system to fight. Social media enabled companies to reach out to and enroll study volunteers, and plenty of people wanted to help, so there were enough research participants to test the COVID-19 vaccines. Because SARS-CoV-2 is so contagious and widespread, many volunteers who got the vaccines were exposed to the virus, and with so many exposures, it took a shorter time to see if the vaccines worked. Companies began manufacturing vaccines ahead of their authorization or approval so some supplies would be ready if authorization occurred. Where do you get your info ?